Xu Ye
283 Tongzipo Road
Changsha, 410013, China
Changsha, 410013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in Patients with Platinum-Resistant or Immunotherapy-Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective, Real-World Study.
Journal: Drug design, development and therapy
Published: March 19, 2026
Diagnostic Performance of Serum AKR1B10 in Early-Stage and AFP-Negative Hepatocellular Carcinoma: A Multicentre Study.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 03, 2026
AKR1B10 as a serum marker for diagnosis and postoperative monitoring of hepatocellular carcinoma.
Journal: British journal of cancer
Published: August 04, 2025
The detection of serum-volatile organic compounds in the diagnostics of hepatocellular carcinoma using gas chromatography-ion mobility spectrometry.
Journal: Frontiers in chemistry
Published: July 24, 2025
A Large-Scale Retrospective Study of Serum Des-Gamma-Carboxy Prothrombin as a Diagnostic Marker of HCC: Effect of Liver Function on Specificity.
Journal: Journal of clinical laboratory analysis
Published: January 10, 2025
In Reply to Kite et al.
Journal: International journal of radiation oncology, biology, physics
Published: January 03, 2025
Reirradiation based on diffusion-weighted magnetic resonance imaging-guided dose- painting for locally advanced recurrent nasopharyngeal carcinoma: a phase 2 randomized controlled trial.
Journal: BMC cancer
Published: November 06, 2024
Aldo-keto reductase 1B10 as a Carcinogenic but Not a Prognostic Factor in Colorectal Cancer.
Journal: Journal of Cancer
Published: October 13, 2023
A randomized, controlled trial to investigate cognitive behavioral therapy in prevention and treatment of acute oral mucositis in patients with locoregional advanced nasopharyngeal carcinoma undergoing chemoradiotherapy.
Journal: Frontiers in oncology
Published: January 12, 2023
Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma.
Journal: Journal of gastroenterology
Published: December 17, 2022
Prognostic Value of a Serum Panel of Inflammatory Factors in Non-Metastatic Nasopharyngeal Carcinoma Patients Undergoing Radical Radiotherapy with Adjuvant Chemotherapy.
Journal: Cancer management and research
Published: May 06, 2022
Development of a prognostic signature for bladder cancer based on immune-related genes.
Journal: Annals of translational medicine
Published: December 14, 2020
Last Updated: 09/26/2026